Published in J Biomol Screen on June 24, 2005
Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain (2007) 6.98
Recommendations for the management of herpes zoster. Clin Infect Dis (2007) 4.33
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol (2003) 3.80
Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial. JAMA (2004) 3.47
Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature (2006) 3.45
TP53 mutation and survival in chronic lymphocytic leukemia. J Clin Oncol (2010) 3.26
Bendamustine combined with rituximab in patients with relapsed and/or refractory chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group. J Clin Oncol (2011) 3.21
Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor. Science (2003) 3.19
Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci U S A (2009) 3.01
Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group. J Clin Oncol (2012) 3.00
NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. Lancet Neurol (2008) 2.60
miR-34a as part of the resistance network in chronic lymphocytic leukemia. Blood (2008) 2.58
Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations. Pain (2006) 2.23
Treatment of postmastectomy pain with ambulatory continuous paravertebral nerve blocks: a randomized, triple-masked, placebo-controlled study. Reg Anesth Pain Med (2014) 2.20
Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia. J Clin Oncol (2006) 2.15
Cervical transforaminal epidural steroid injections: more dangerous than we think? Spine (Phila Pa 1976) (2007) 2.10
Subcutaneous alemtuzumab in fludarabine-refractory chronic lymphocytic leukemia: clinical results and prognostic marker analyses from the CLL2H study of the German Chronic Lymphocytic Leukemia Study Group. J Clin Oncol (2009) 2.00
Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival. Haematologica (2007) 1.99
Multicenter trial of high-speed versus conventional single-photon emission computed tomography imaging: quantitative results of myocardial perfusion and left ventricular function. J Am Coll Cardiol (2010) 1.93
The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0. J Nucl Med (2012) 1.84
The tinnitus functional index: development of a new clinical measure for chronic, intrusive tinnitus. Ear Hear (2012) 1.61
The effect of opioids on sleep architecture. J Clin Sleep Med (2007) 1.61
High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations. Blood (2012) 1.58
Nanomolar inhibitors of Staphylococcus aureus methionyl tRNA synthetase with potent antibacterial activity against gram-positive pathogens. J Med Chem (2002) 1.42
PET myocardial glucose metabolism and perfusion imaging: Part 1-Guidelines for data acquisition and patient preparation. J Nucl Cardiol (2003) 1.39
Tutorials in clinical research: part IV: recognizing and controlling bias. Laryngoscope (2002) 1.19
Methodological aspects of clinical trials in tinnitus: a proposal for an international standard. J Psychosom Res (2012) 1.19
Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging. J Nucl Med (2004) 1.17
Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes. Blood (2005) 1.16
Intraoperative MRI to guide the resection of primary supratentorial glioblastoma multiforme--a quantitative radiological analysis. Neuroradiology (2005) 1.15
Electrical stimulation for intraoperative evaluation of thoracic pedicle screw placement. Spine (Phila Pa 1976) (2003) 1.11
A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain. J Pain Symptom Manage (2006) 1.11
NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSG. Blood (2013) 1.09
Sestamibi scanning and minimally invasive radioguided parathyroidectomy without intraoperative parathyroid hormone measurement. Ann Surg (2003) 1.08
FLIM FRET technology for drug discovery: automated multiwell-plate high-content analysis, multiplexed readouts and application in situ. Chemphyschem (2011) 1.08
Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism. Bioorg Med Chem (2013) 1.07
Hybrid imaging (SPECT/CT and PET/CT): improving therapeutic decisions. Semin Nucl Med (2009) 1.05
Cerebral lesions incidentally detected on 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography images of patients evaluated for body malignancies. Mol Imaging Biol (2002) 1.02
Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain. Pain Physician (2011) 1.02
Comparing the USA, UK and 17 Western countries' efficiency and effectiveness in reducing mortality. JRSM Short Rep (2011) 1.00
Efficacy of noradrenergic and serotonergic antidepressants in chronic back pain: a preliminary concentration-controlled trial. J Clin Psychopharmacol (2007) 0.99
CT-based attenuation correction versus prone imaging to decrease equivocal interpretations of rest/stress Tc-99m tetrofosmin SPECT MPI. J Nucl Cardiol (2007) 0.97
Long-term effectiveness and tolerability of sublingual fentanyl orally disintegrating tablet for the treatment of breakthrough cancer pain. Curr Med Res Opin (2011) 0.97
Automated fluorescence lifetime imaging plate reader and its application to Förster resonant energy transfer readout of Gag protein aggregation. J Biophotonics (2012) 0.96
Hearing aids as an adjunct to counseling: tinnitus patients who choose amplification do better than those that don't. Int J Audiol (2010) 0.96
Intrathecal ziconotide for neuropathic pain: a review. Pain Pract (2009) 0.95
A novel paradigm to trigger apoptosis in chronic lymphocytic leukemia. Cancer Res (2009) 0.94
Shaping a screening file for maximal lead discovery efficiency and effectiveness: elimination of molecular redundancy. J Chem Inf Model (2012) 0.93
Rapid analysis of Forster resonance energy transfer by two-color global fluorescence correlation spectroscopy: trypsin proteinase reaction. Biophys J (2005) 0.93
Tutorials in clinical research: VII. Understanding comparative statistics (contrast)--part B: application of T-test, Mann-Whitney U, and chi-square. Laryngoscope (2003) 0.93
The INFUSE-Morphine study: use of recombinant human hyaluronidase (rHuPH20) to enhance the absorption of subcutaneously administered morphine in patients with advanced illness. J Pain Symptom Manage (2009) 0.92
Gene expression factors as predictors of genetic risk and survival in chronic lymphocytic leukemia. Haematologica (2009) 0.91
Intradermal capsaicin causes dose-dependent pain, allodynia, and hyperalgesia in humans. J Investig Med (2006) 0.91
A randomized controlled trial of gabapentin for chronic low back pain with and without a radiating component. Pain (2016) 0.90
An integrated metabonomic approach to describe temporal metabolic disregulation induced in the rat by the model hepatotoxin allyl formate. J Proteome Res (2006) 0.90
Update of PET and PET/CT for hepatobiliary and pancreatic malignancies. HPB (Oxford) (2005) 0.90
Long-term safety, tolerability, and consistency of effect of fentanyl pectin nasal spray for breakthrough cancer pain in opioid-tolerant patients. J Opioid Manag (2010) 0.89
Effects of subthalamic nucleus stimulation on striatal dopaminergic transmission in patients with Parkinson's disease within one-year follow-up. J Neurol (2008) 0.89
PET and PET-CT for evaluation of colorectal carcinoma. Semin Nucl Med (2004) 0.89
A bioluminogenic HDAC activity assay: validation and screening. J Biomol Screen (2011) 0.89
DNA damage-induced transcriptional program in CLL: biological and diagnostic implications for functional p53 testing. Blood (2010) 0.89
Qualitative and quantitative characterization of the thermal grill. Pain (2005) 0.88
Discovery and structure-activity relationship of potent and selective covalent inhibitors of transglutaminase 2 for Huntington's disease. J Med Chem (2012) 0.87
Update on pharmacotherapy guidelines for the treatment of neuropathic pain. Curr Pain Headache Rep (2006) 0.87
BRAF mutations in chronic lymphocytic leukemia. Leuk Lymphoma (2012) 0.87
Pharmacometabonomics in humans: a new tool for personalized medicine. Pharmacogenomics (2015) 0.86
2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography uptake in a giant adrenal myelolipoma. Mol Imaging Biol (2002) 0.85
Identification of novel Kv1.3 blockers using a fluorescent cell-based ion channel assay. J Biomol Screen (2005) 0.85
Longitudinal pharmacometabonomics for predicting patient responses to therapy: drug metabolism, toxicity and efficacy. Expert Opin Drug Metab Toxicol (2012) 0.85
Human experimental pain models 2: the cold pressor model. Methods Mol Biol (2010) 0.85
Ala228 variant of trail receptor 1 affecting the ligand binding site is associated with chronic lymphocytic leukemia, mantle cell lymphoma, prostate cancer, head and neck squamous cell carcinoma and bladder cancer. Int J Cancer (2006) 0.85
Targeting voltage-gated calcium channels for the treatment of neuropathic pain: a review of drug development. Expert Opin Investig Drugs (2011) 0.84
Design, synthesis, and pharmacology of fluorescently labeled analogs of serotonin: application to screening of the 5-HT2C receptor. J Biomol Screen (2009) 0.84
An hypothesis for a mechanism underlying hepatotoxin-induced hypercreatinuria. Arch Toxicol (2003) 0.84
Once-daily gastroretentive gabapentin for postherpetic neuralgia: integrated efficacy, time to onset of pain relief and safety analyses of data from two phase 3, multicenter, randomized, double-blind, placebo-controlled studies. J Pain Symptom Manage (2012) 0.84
Unsuspected skeletal sarcoidosis mimicking metastatic disease on FDG positron emission tomography and bone scintigraphy. Clin Nucl Med (2003) 0.84
CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseases. J Biol Chem (2003) 0.84
Hepatotoxin-induced hypertyrosinemia and its toxicological significance. Arch Toxicol (2006) 0.84
PET and PET/CT for pancreatic malignancies. Surg Oncol Clin N Am (2010) 0.83
Development of a series of aryl pyrimidine kynurenine monooxygenase inhibitors as potential therapeutic agents for the treatment of Huntington's disease. J Med Chem (2015) 0.83
'OnePoint'--combining OneNote and SharePoint to facilitate knowledge transfer. Drug Discov Today (2009) 0.83
Early autologous stem cell transplantation for chronic lymphocytic leukemia: long-term follow-up of the German CLL Study Group CLL3 trial. Blood (2012) 0.83
Development of a 1-microl scale assay for mitogen-activated kinase kinase 7 using 2-D fluorescence intensity distribution analysis anisotropy. J Biomol Screen (2002) 0.83
Gabapentin for once-daily treatment of post-herpetic neuralgia: a review. Clin Interv Aging (2012) 0.82
Property- and structure-guided discovery of a tetrahydroindazole series of interleukin-2 inducible T-cell kinase inhibitors. J Med Chem (2014) 0.82
Human experimental pain models 3: heat/capsaicin sensitization and intradermal capsaicin models. Methods Mol Biol (2010) 0.82
Fragment-based identification of Hsp90 inhibitors. ChemMedChem (2009) 0.82
Continuous Intrathecal Infusion of Ziconotide for Treatment of Chronic Malignant and Nonmalignant Pain Over 12 Months: A Prospective, Open-label Study. Neuromodulation (2008) 0.82
Persistent postmastectomy pain and pain-related physical and emotional functioning with and without a continuous paravertebral nerve block: a prospective 1-year follow-up assessment of a randomized, triple-masked, placebo-controlled study. Ann Surg Oncol (2014) 0.81
Treating intractable phantom limb pain with ambulatory continuous peripheral nerve blocks: a pilot study. Pain Med (2013) 0.81
[18F]Fluorodeoxyglucose positron emission tomography surveillance of hepatic metastases from prostate cancer following radiofrequency ablation: a case report. Am Surg (2003) 0.81
Development of a colorimetric and a fluorescence phosphatase-inhibitor assay suitable for drug discovery approaches. J Biomol Screen (2013) 0.81
Intrathecal gabapentin to treat chronic intractable noncancer pain. Anesthesiology (2013) 0.81